We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App





Sekisui Diagnostics Showcases Clinical Chemistry and Immunoassay Analyzers

By LabMedica International staff writers
Posted on 31 Jul 2018
Print article
Image: The SK500 clinical chemistry system (Photo courtesy of Sekisui Diagnostics).
Image: The SK500 clinical chemistry system (Photo courtesy of Sekisui Diagnostics).
Sekisui Diagnostics (Lexington, MA, USA) showcased its clinical chemistry and immunoassay analyzers, including the SK500 clinical chemistry system and FastPack IP System, at the 70th Annual Scientific Meeting & Clinical Lab Expo held by the American Association for Clinical Chemistry (AACC) on July 29 – August 2, 2018 in Chicago, USA. AACC is the largest global scientific conference and tradeshow in laboratory medicine, with ~20,000 attendees and 750 exhibitors from around the world. AACC 2018 also provided Plenary Sessions featuring world-renowned scientists and scientific sessions covering a broad range of subjects at various experience levels, and focused “Brown Bag” sessions that gave attendees the opportunity to pose questions in small groups.

Sekisui Diagnostics provides diagnostic products in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems. The company’s product lines include clinical chemistry systems and reagents, coagulation systems and reagents, point of care rapid tests and immunoassay system, enzymes and specialty biochemical.

The SK500 Clinical Chemistry System showcased by Sekisui Diagnostics at AACC 2018 is a compact and efficient instrument with a full menu of high quality reagents specifically designed and packaged for the system, including the addition of a drugs of abuse testing menu. Sekisui Diagnostics also showcased the FastPack IP System, a fully automated quantitative immunoassay analyzer which uses sophisticated chemiluminescence technology to deliver accurate test results for commonly ordered tests in 12 minutes or less with a push of a button.

Also featured at the event was the company’s recently launched Silaris Influenza A&B Test which utilizes an affordable, polymerase chain reaction (PCR) testing platform specifically for point of care infectious disease diagnosis. It offers the simplicity, convenience and procedural familiarity of traditional visual read rapid tests, while providing the superior sensitivity and specificity of laboratory-based PCR testing.

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
All-in-one Molecular Diagnosis System
Panall 8000

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.